Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Han, Lin Lin ^a   Hou, Lin ^a   Zhou, Ming Jin ^b   Ma, Zhong Liang ^c   Lin, Dong Liang ^c   Wu, Li ^c   Ge, Yin Lin ^a  

^a QINGDAO UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Affiliated Hospital of Qingdao   (China)

Author keywords

Breast cancer; DNA methylation; Gene expression; N myc downstream regulated gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CPG OLIGODEOXYNUCLEOTIDE; NDRG1 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; AZACITIDINE; CELL CYCLE PROTEIN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; SIGNAL PEPTIDE; DRUG DERIVATIVE; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; DNA METHYLATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; BREAST TUMOR; CELL DIFFERENTIATION; CPG ISLAND; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; PATHOLOGY; TUMOR CELL LINE; DRUG EFFECT;

AZACITIDINE; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC;

EID: 84880892927     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-52     Document Type: Article

References (26)

1. Breast cancer statistics, 2011. DeSantis C, Siegel R, Bandi P, Jemal A, CA Cancer J Clin 2011 61 6 409 418 21969133
2. A novel gene which is up-regulated during colon epithelial ell differentiation and down-regulated in colorectal neoplasms. Van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT, Lab Invest 1997 77 1 85 92 9251681 (Pubitemid 27328362)
3. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Piquemal D, Commes T, Watabe M, Gross SC, Wang Y, Ran S, Watabe K, Oncogene 2004 23 33 5675 5681 10.1038/sj.onc.1207734 15184886 (Pubitemid 39093045)
4. p53 protein accumulates frequently in early bronchial neoplasia. Bennett WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, Metcalf RA, Samet JM, Takeshima Y, Gu JR, et al. Cancer Res 1993 53 20 4817 4822 8402667 (Pubitemid 23326172)
5. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW, Cancer Res 1998 58 19 4439 4444 9766676 (Pubitemid 28450049)
6. DNA methylation and gene silencing in cancer: which is the guilty party? Clark SJ, Melki J, Oncogene 2002 21 35 5380 5387 10.1038/sj.onc.1205598 12154400 (Pubitemid 34983474)
7. The epigenomics of cancer. Jones PA, Baylin SB, Cell 2007 128 4 683 692 10.1016/j.cell.2007.01.029 17320506 (Pubitemid 46273572)
8. Involvement of DNA methylation in human carcinogenesis. Schmutte C, Jones PA, Biol Chem 1998 379 4-5 377 388 9628328 (Pubitemid 28209908)
9. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC, Cancer Res 1999 59 1 159 164 9892201 (Pubitemid 29062972)
10. Large chromatin domains in pluripotent and differentiated cells. Hu S, Cheng L, Wen B, Acta Biochim Biophys Sin (Shanghai) 2012 44 1 48 53 10.1093/abbs/gmr108
11. N-myc downstream-regulated gene 1 (Drg-1) a differentiation marker of human breast cancer. Fotovati A, Abu-Ali S, Kage M, Shirouzu K, Yamana H, Kuwano M, Pathol Oncol Res 2011 17 3 525 533 10.1007/s12253-010-9342-y 21221878
12. Cellular differentiation determines the expression of the hypoxia-inducible protein Drg-1 in pancreatic cancer. Angst E, Sibold S, Tiffon C, Weimann R, Gloor B, Candinas D, Stroka D, Br J Cancer 2006 95 3 307 313 10.1038/sj.bjc.6603256 16832411 (Pubitemid 44187591)
13. Epigenetic regulation affects N-myc downstream regulated gene-1 expression indirectly in pancreatic cancer cells. Angst E, Dawson DW, Nguyen A, Park J, Go VL, Reber HA, Hines OJ, Eibl G, Pancreas 2010 39 5 675 679 10.1097/MPA.0b013e3181c8b476 20173668
14. Association of NDRG1 Gene Promoter Methylation with Reduced NDRG1 Expression in Gastric Cancer Cells and Tissue Specimens. Chang X, Zhang S, Ma J, Li Z, Zhi Y, Chen J, Lu Y, Dai D, Cell Biochem Biophys 2012 66 1 93 101
15. Transcriptional silencing of N-Myc downstream-regulated gene 1 (Drg-1) in metastatic colon cancer cell line SW620. Li Q, Chen H, Clin Exp Metastasis 2011 28 2 127 135 10.1007/s10585-010-9366-4 21184144
16. Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. Veronesi U, Viale G, Rotmensz N, Goldhirsch A, Breast 2006 15 1 3 8 16473737 (Pubitemid 43210543)
17. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC, Gastroenterology 2006 131 6 1835 1843 10.1053/j.gastro.2006.09.050 17087954 (Pubitemid 44958519)
18. DNA methylation and cancer. Das PM, Singal R, J Clin Oncol 2004 22 22 4632 4642 10.1200/JCO.2004.07.151 15542813 (Pubitemid 41185132)
19. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, Rosenthal A, King RH, Thomas PK, Am J Hum Genet 2000 67 1 47 58 10.1086/302978 10831399 (Pubitemid 30481543)
20. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Schnitt SJ, Mod Pathol 2010 23 Suppl 2 60 s64 20436504
21. N-myc downstream regulated gene-1/ Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Song Y, Oda Y, Hori M, Kuroiwa K, Ono M, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S, Tsuneyoshi M, Hum Pathol 2010 41 2 214 222 10.1016/j.humpath.2009.07.011 19800102
22. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, Aoyagi S, Kinoshita H, Kuwano M, Cancer Res 2006 66 12 6233 6242 10.1158/0008-5472.CAN-06-0183 16778198
23. Breast differentiation and its implication in cancer prevention. Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH, Clin Cancer Res 2005 11 2 Pt 2 931s 936s 15701889 (Pubitemid 40111108)
24. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Page DL, Am J Surg Pathol 1991 15 4 334 349 10.1097/00000478-199104000-00002 2006713
25. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its MDA-MB-231with clinicopathological features and clinical outcome. Zhang SB, Song SP, Li B, Zhou YS, Zhang YD, Med Oncol 2012 29 3 1866 1872 10.1007/s12032-011-0017-7 21735144
26. A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Jiang K, Shen Z, Ye Y, Yang X, Wang S, Scand J Gastroenterol 2010 45 7-8 898 908 20388062